Itay Perets1,2, Matthew J Craig1,3, Brian H Mu1, David R Maldonado1, Jody M Litrenta4, Benjamin G Domb1,5. 1. American Hip Institute, Westmont, Illinois, USA. 2. Hadassah Hebrew University Hospital, Jerusalem, Israel. 3. University of Illinois at Chicago, Chicago, Illinois, USA. 4. New York University Langone Orthopedic Hospital, New York, New York, USA. 5. Hinsdale Orthopaedics, Westmont, Illinois, USA.
Abstract
BACKGROUND: Hip arthroscopy is an established surgical treatment for pathologic hip conditions in athletes. There is a paucity in the literature regarding outcomes and return to sport for athletes in the midterm. PURPOSE: To report minimum 5-year outcomes, return to sport, and level of sport among athletic patients who underwent hip arthroscopy. In addition, we compared 2- and 5-year outcomes to evaluate whether there is a deterioration in functional status. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Data were prospectively collected on all patients who underwent hip arthroscopy between February 2009 and November 2011 at 1 institution. Athletes at the high school, collegiate, or professional level who underwent hip arthroscopy and had preoperative patient-reported outcome (PRO) scores were considered for inclusion. Exclusion criteria were preoperative Tönnis grade >1 or prior ipsilateral hip conditions or surgery. Data on sports participation, competition level, and ability were collected. At a minimum of 5 years postoperatively, PROs, visual analog scale (VAS), iHOT-12 (short version of International Hip Outcome Tool), satisfaction, and postoperative complication data were collected. RESULTS: Seventy-seven hips met all criteria, among which 66 (85.7%) had a minimum 5-year follow-up and were included. There were 37 high school, 20 collegiate, and 9 professional athletes. Mean ± SD improvements at a minimum of 5 years were as follows: modified Harris Hip Score, 66.8 ± 16.3 to 87.0 ± 14.8 ( P < .001); nonarthritic hip score, 66.2 ± 19.9 to 87.2 ± 15.2 ( P < .001); Hip Outcome Score-Sports Specific Subscale, 47.0 ± 22.4 to 79.1 ± 23.0 ( P < .001); and VAS, 5.4 ± 2.5 to 1.8 ± 2.1 ( P < .001). At latest follow-up, mean iHOT-12 was 78.8 ± 22.7, and satisfaction was 8.2. A total of 50 athletes (53 hips, 80.3%) reported that they returned to sports; 71.2% reported "same" or "higher" sport ability as compared with a year before surgery. Postoperative complications included 3 cases (4.5%) of numbness and 1 case (1.5%) of pulmonary embolism. Ten hips (15.2%) required secondary arthroscopies, and no hips were converted to total hip arthroplasty. There were no significant differences between 2- and 5-year PROs, VAS, or satisfaction. CONCLUSION: Midterm results of hip arthroscopy in athletes are shown to be safe and favorable. Most athletes return to sports and continue to play after 5 years with the same or higher ability.
BACKGROUND: Hip arthroscopy is an established surgical treatment for pathologic hip conditions in athletes. There is a paucity in the literature regarding outcomes and return to sport for athletes in the midterm. PURPOSE: To report minimum 5-year outcomes, return to sport, and level of sport among athletic patients who underwent hip arthroscopy. In addition, we compared 2- and 5-year outcomes to evaluate whether there is a deterioration in functional status. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: Data were prospectively collected on all patients who underwent hip arthroscopy between February 2009 and November 2011 at 1 institution. Athletes at the high school, collegiate, or professional level who underwent hip arthroscopy and had preoperative patient-reported outcome (PRO) scores were considered for inclusion. Exclusion criteria were preoperative Tönnis grade >1 or prior ipsilateral hip conditions or surgery. Data on sports participation, competition level, and ability were collected. At a minimum of 5 years postoperatively, PROs, visual analog scale (VAS), iHOT-12 (short version of International Hip Outcome Tool), satisfaction, and postoperative complication data were collected. RESULTS: Seventy-seven hips met all criteria, among which 66 (85.7%) had a minimum 5-year follow-up and were included. There were 37 high school, 20 collegiate, and 9 professional athletes. Mean ± SD improvements at a minimum of 5 years were as follows: modified Harris Hip Score, 66.8 ± 16.3 to 87.0 ± 14.8 ( P < .001); nonarthritic hip score, 66.2 ± 19.9 to 87.2 ± 15.2 ( P < .001); Hip Outcome Score-Sports Specific Subscale, 47.0 ± 22.4 to 79.1 ± 23.0 ( P < .001); and VAS, 5.4 ± 2.5 to 1.8 ± 2.1 ( P < .001). At latest follow-up, mean iHOT-12 was 78.8 ± 22.7, and satisfaction was 8.2. A total of 50 athletes (53 hips, 80.3%) reported that they returned to sports; 71.2% reported "same" or "higher" sport ability as compared with a year before surgery. Postoperative complications included 3 cases (4.5%) of numbness and 1 case (1.5%) of pulmonary embolism. Ten hips (15.2%) required secondary arthroscopies, and no hips were converted to total hip arthroplasty. There were no significant differences between 2- and 5-year PROs, VAS, or satisfaction. CONCLUSION: Midterm results of hip arthroscopy in athletes are shown to be safe and favorable. Most athletes return to sports and continue to play after 5 years with the same or higher ability.
Entities:
Keywords:
athletes; clinical outcomes; hip arthroscopy; midterm; return to sports
Authors: David A Bloom; Daniel J Kaplan; David J Kirby; Daniel B Buchalter; Charles C Lin; Jordan W Fried; Nainisha Chintalapudi; Thomas Youm Journal: Knee Surg Sports Traumatol Arthrosc Date: 2021-11-05 Impact factor: 4.342
Authors: David R Maldonado; Sarah L Chen; Mitchell J Yelton; Philip J Rosinsky; Rafael Walker-Santiago; Jacob Shapira; Ajay C Lall; Benjamin G Domb Journal: Orthop J Sports Med Date: 2020-02-05
Authors: Lorenz Büchler; Valentin Grob; Helen Anwander; Till D Lerch; Pascal C Haefeli Journal: Clin Orthop Relat Res Date: 2021-10-01 Impact factor: 4.755
Authors: David R Maldonado; Mitchell J Yelton; Philip J Rosinsky; Jacob Shapira; Mitchell B Meghpara; Ajay C Lall; Benjamin G Domb Journal: BMC Musculoskelet Disord Date: 2020-06-23 Impact factor: 2.362
Authors: Robert A Jack; Kyle R Sochacki; Takashi Hirase; Justin Vickery; Patrick C McCulloch; David M Lintner; Joshua D Harris Journal: Orthop J Sports Med Date: 2019-02-22
Authors: Joshua S Everhart; Sarah Poland; Sravya P Vajapey; James C Kirven; Thomas J France; W Kelton Vasileff Journal: J Hip Preserv Surg Date: 2020-01-30
Authors: Jesus Mas Martinez; Javier Sanz-Reig; Carmen Verdu Roman; David Bustamante Suarez de Puga; Enrique Martinez Gimenez; Manuel Morales Santias Journal: Arthrosc Sports Med Rehabil Date: 2020-07-29
Authors: Alexander E Weber; Haley Nakata; Eric N Mayer; Ioanna K Bolia; Marc J Philippon; Jason Snibbe; Russ Romano; James E Tibone; Seth C Gamradt Journal: Orthop J Sports Med Date: 2020-05-22
Authors: Ida Lindman; Axel Öhlin; Neel Desai; Kristian Samuelsson; Olufemi R Ayeni; Eric Hamrin Senorski; Mikael Sansone Journal: Am J Sports Med Date: 2020-03-20 Impact factor: 6.202